Literature DB >> 16763681

Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.

Eliane Schweizer1, Anja Hoffmann-Röder, Jacob A Olsen, Paul Seiler, Ulrike Obst-Sander, Björn Wagner, Manfred Kansy, David W Banner, François Diederich.   

Abstract

Two series of tricyclic inhibitors of the serine protease thrombin, imides (+/-)-1-(+/-)-8 and lactams (+/-)-9-(+/-)-13, were analysed to evaluate contributions of orthogonal multipolar interactions with the backbone C=O moiety of Asn98 to the free enthalpy of protein-ligand complexation. The lactam derivatives are much more potent and more selective inhibitors (K(i) values between 0.065 and 0.005 microM, selectivity for thrombin over trypsin between 361- and 1609-fold) than the imide compounds (Ki values between 0.057 and 23.7 microM, selectivity for thrombin over trypsin between 3- and 67-fold). The increase in potency and selectivity is explained by the favorable occupancy of the P-pocket of thrombin by the additional isopropyl substituent in the lactam derivatives. The nature of the substituent on the benzyl ring filling the D pocket strongly influences binding potency in the imide series, with Ki values increasing in the sequence: F < OCH2O < Cl < H < OMe < OH < N(pyr)<< Br. This sequence can be explained by both steric fit and the occurrence of orthogonal multipolar interactions with the backbone C[double bond, length as m-dash]O moiety of Asn98. In contrast, the substituent on the benzyl ring hardly affects the ligand potency in the lactam series. This discrepancy was clarified by the comparison of X-ray structures solved for co-crystals of thrombin with imide and lactam ligands. Whereas the benzyl substituents in the imide inhibitors are sufficiently close (< or =3.5 Angstroms) to the C=O group of Asn98 to allow for attractive orthogonal multipolar interactions, the distances in the lactam series are too large (> or =4 Angstroms) for attractive dipolar contacts to be effective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763681     DOI: 10.1039/b602585d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.

Authors:  Orazio Nicolotti; Ilenia Giangreco; Teresa Fabiola Miscioscia; Marino Convertino; Francesco Leonetti; Leonardo Pisani; Angelo Carotti
Journal:  J Comput Aided Mol Des       Date:  2010-02-11       Impact factor: 3.686

2.  Significant enhancement of docking sensitivity using implicit ligand sampling.

Authors:  Mengang Xu; Markus A Lill
Journal:  J Chem Inf Model       Date:  2011-03-04       Impact factor: 4.956

3.  Rationalizing tight ligand binding through cooperative interaction networks.

Authors:  Bernd Kuhn; Julian E Fuchs; Michael Reutlinger; Martin Stahl; Neil R Taylor
Journal:  J Chem Inf Model       Date:  2011-12-09       Impact factor: 4.956

4.  Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor.

Authors:  Wonhwa Lee; Suyeon Lee; Joonhyeok Choi; Jun-Hyeong Park; Kyung-Min Kim; Jun-Goo Jee; Jong-Sup Bae
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

5.  Synthesis and Biological Activity of Benzamides Substituted with Pyridine-Linked 1,2,4-Oxadiazole.

Authors:  Sen Yang; Xiao-Yu Tian; Tian-Yang Ma; Li Dai; Chao-Li Ren; Jun-Chang Mei; Xing-Hai Liu; Cheng-Xia Tan
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.